Dermatologic and Ophthalmic Drugs Advisory Committee - PDFSEARCH.IO - Document Search Engine

Dermatologic and Ophthalmic Drugs Advisory Committee
Results: 196

#	Item
91	Food and Drug Administration Center for Drug Evaluation and Research Summary Minutes of the Dermatologic and Ophthalmic Drugs Advisory Committee June 17, 2011 Add to Reading List Source URL: www.fda.gov Language: English Pharmaceutical sciences Dermatologic and Ophthalmic Drugs Advisory Committee Center for Drug Evaluation and Research Ketorolac Vascular endothelial growth factor George Yancopoulos Macular degeneration Food and Drug Administration Medicine Health
92	Capital Reporting Company Dermatologic And Ophthalmic Drugs Advisory Committee[removed]FOOD AND DRUG ADMINISTRATION CENTER FOR DRUG EVALUATION AND RESEARCH Add to Reading List Source URL: www.fda.gov Language: English Pharmaceutical sciences Dermatologic and Ophthalmic Drugs Advisory Committee Center for Drug Evaluation and Research Ophthalmology Food and Drug Administration Medicine Health
93	FOOD AND DRUG ADMINISTRATION Center for Drug Evaluation and Research Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC) Meeting DoubleTree by Hilton Hotel Washington DC-Silver Spring Silver Spring, Maryland Feb Add to Reading List Source URL: www.fda.gov Language: English Piperazines Chemistry Pharmacology Dermatologic and Ophthalmic Drugs Advisory Committee Food and Drug Administration Non-steroidal anti-inflammatory drugs
94	FOOD AND DRUG ADMINISTRATION Center for Drug Evaluation and Research Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC) Meeting DoubleTree by Hilton Hotel Washington DC-Silver Spring Silver Spring, Maryland Feb Add to Reading List Source URL: www.fda.gov Language: English Chemistry Piperazines Pharmacology Dermatologic and Ophthalmic Drugs Advisory Committee Food and Drug Administration Non-steroidal anti-inflammatory drugs
95	FOOD AND DRUG ADMINISTRATION (FDA) Center for Drug Evaluation and Research (CDER) Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC) Meeting FDA White Oak Campus, Building 31, The Great Room (Rm[removed]White Oa Add to Reading List Source URL: www.fda.gov Language: English Food and Drug Administration Dermatologic and Ophthalmic Drugs Advisory Committee Macula of retina Adhesion Macular hole Health Medicine Pharmaceutical sciences
96	FOOD AND DRUG ADMINISTRATION Center for Drug Evaluation and Research Joint Meeting of the Drug Safety and Risk Management Advisory Committee (DSaRM) and the Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC) FD Add to Reading List Source URL: www.fda.gov
97	Summary Minutes of the Drug Safety and Risk Management Advisory Committee and the Dermatologic and Ophthalmic Drugs Advisory Committee December 1, 2011 Location: FDA White Oak Campus, Building 31, the Great Room, White Add to Reading List Source URL: www.fda.gov Language: English Pharmacy Food and Drug Administration Dermatologic and Ophthalmic Drugs Advisory Committee Isotretinoin IPLEDGE Adverse effect Pharmaceutical industry Pharmaceutical sciences Pharmacology Medicine
98	FOOD AND DRUG ADMINISTRATION (FDA) CENTER FOR DRUG EVALUATION AND RESEARCH (CDER) Dermatologic and Ophthalmic Drugs Advisory Committee Marriott Inn and Conference Center University of Maryland University College (UMUC) A Add to Reading List Source URL: www.fda.gov Language: English Dermatologic and Ophthalmic Drugs Advisory Committee Food and Drug Administration Vascular endothelial growth factor Macular degeneration Q4 Ketorolac Medicine Pharmaceutical sciences Health
99	FOOD AND DRUG ADMINISTRATION Center for Drug Evaluation and Research Joint Meeting of the Drug Safety and Risk Management Advisory Committee (DSaRM) and the Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC) FD Add to Reading List Source URL: www.fda.gov
100	Food and Drug Administration Center for Drug Evaluation and Research Summary Minutes of the Dermatologic and Ophthalmic Drugs Advisory Committee Meeting July 26, 2012 Topic: During the morning session, the committee dis Add to Reading List Source URL: www.fda.gov Language: English Monoclonal antibodies Ranibizumab Genentech Macular degeneration Macular edema Wills Eye Institute Diabetic retinopathy Bevacizumab Ophthalmology Medicine Vision